Correlation
Test whether higher Energy Score values are associated with higher Measured Function Score values at the same visit.
A proposed observational validation study testing whether the model-derived Energy Score from Mito Map correlates with the newly built Measured Function Score, which combines grip strength, 5x sit-to-stand, chair-support adjustments, and fatigue burden.
Test whether higher Energy Score values are associated with higher Measured Function Score values at the same visit.
Test whether change in one score tracks change in the other across repeated visits.
Test whether baseline Energy Score predicts later function and whether baseline measured function predicts later model output.
The Energy Score is a mechanistic estimate built from age, mutation context, graph burden, phenotype burden, patient-state burden, interventions, and optionally labs. The Measured Function Score is an observed output score built from actual performance and symptom burden. In theory, if the mechanistic model is capturing real biologic reserve, it should correlate with observed performance and patient-reported fatigue.
This trial treats the Measured Function Score as a pragmatic external anchor. It is not a gold standard for mitochondrial function, but it is a low-cost, repeatable, clinically interpretable output bundle. If the two scores correlate moderately well, that would support convergent validity. If they diverge, that tells you where the model may need recalibration or where observed function may be influenced by factors the graph does not yet capture.
Directly relevant because it includes 5XSST and Fatigue Severity Scale among outcome measures in PMM.
Supports longitudinal use of 5XSST and fatigue measures in mitochondrial disease.
Supports the excellent reliability of the five-times sit-to-stand test across adult populations.
Supports standardization choices for how the chair-rise test should be run and interpreted.
Supports grip strength as a broad marker of health and functional risk, even if not mitochondria-specific.
Supports the use of sex-specific reference curves for grip and 5x sit-to-stand scaling.
No. The proposed first study is observational. The goal is to validate correlation and tracking before running interventional studies.
Those would be stronger biologic anchors, but they are much harder and more expensive to deploy. This first trial is designed to be feasible and fast.
Even a moderate, stable correlation would be useful at this stage, especially if change over time also tracks in the expected direction.
Yes. That is one reason the mechanistic graph still matters. The Measured Function Score tells you how the person is functioning, while Mito Map is trying to explain why.
Success would mean the model-derived score shows meaningful convergence with observed function, highlights mismatched cases worth studying, and gives you data to recalibrate the system.